Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-Center, Prospective Single Arm Study to Assess the Efficacy and Safety of RETISERT (Intravitreal Flucinolone Acetonide 0.59mg) in Patients With Refractory Ocular Behcet's Disease

NCT00720928 is registered in ClinicalTrials.gov with Asan Medical Center as lead sponsor.

NCT NCT00720928
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00720928 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-Center, Prospective Single Arm Study to Assess the Efficacy and Safety of RETISERT (Intravitreal Flucinolone Acetonide 0.59mg) in Patients With Refractory Ocular Behcet's Disease
Lead sponsor
Asan Medical Center
Phase
Phase 4
Overall status
Unknown status
Start date
July 31, 2008
Completion date
May 31, 2010
Enrollment
15 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

non-infectious uveitis, ocular behcet's disease,, refractory uveitis